Skip to main content
Cureus logoLink to Cureus
. 2024 Mar 1;16(3):e55366. doi: 10.7759/cureus.55366

Efficacy of Bilateral Erector Spinae Block in Patients Undergoing Posterior Spine Fusion Surgeries: A Comparative Randomised Controlled Trial

Suresh Kumar 1, Arish BT 1,, Eashwar Neelakandan 1, Ranjan RV 2, Sivakumar Segaran 1, Prince Solomon 3
Editors: Alexander Muacevic, John R Adler
PMCID: PMC10907871  PMID: 38434605

Abstract

Introduction

During spine surgeries, various levels of tissue injury can result in varying hemodynamic responses and significant postoperative pain. Perioperative pain management is essential to controlling hemodynamic responses and postoperative pain management. Erector spinae plane (ESP) blocks can help alleviate this pain by blocking the dorsal rami of the spinal nerve. This study aims to evaluate the efficacy of ESP by assessing the perioperative opioid requirement, hemodynamic parameters, and visual analogue score (VAS) during the postoperative period.

Methods

In this study, 56 patients underwent elective posterior spine fusion surgeries under conventional anaesthesia and were allocated into two groups: 28 patients were included in the conventional group (Group C) and 28 patients in the ESP group (Group E). Group C patients received 20 ml of 0.9% sodium chloride (NaCl) on each side, and Group E patients received 20 ml of 0.25% bupivacaine + 4 mg dexamethasone on each side under ultrasound sonography guidance. Postoperative pain was assessed using the VAS score. The hemodynamic parameters during the intraoperative period, the time for the first opioid analgesia requirement until 24 hours in the postoperative period, and the amount of cumulative opioid consumption during the perioperative period were observed.

Results

Postoperative VAS was lower in Group E (P < 0.001). There were significant differences in hemodynamic parameters: heart rate (P < 0.045), systolic blood pressure (P < 0.002), diastolic blood pressure (P < 0.003), and mean arterial pressure (P < 0.002) at the time of incision in Group E. Intraoperative opioid requirements at the time of incision (P < 0.036), 60th minutes (P < 0.023), 120th minutes (P < 0.023), and postoperative opioid requirements at the first hour (P < 0.001), sixth hour (P < 0.004), 14th hour (P < 0.025), 20th hour (P < 0.009), and 24th hour (P < 0.025) had lower opioid requirements in Group E than Group C.

Conclusion

ESP block is a more site-specific dorsal rami block with a better perioperative hemodynamic profile, a part of multimodal analgesia intraoperatively, and excellent postoperative analgesia with fewer postoperative opioid requirements in multilevel spine fusion surgeries.

Keywords: opioid consumption, hemodynamic stability, pain scores, perioperative analgesia, posterior spine surgeries, erector spinae block

Introduction

Globally, there is an increased incidence of spine pathologies with varying clinical manifestations, which include back pain, motor weakness, radiating pain to the legs, and entrapment neuropathies. Chronic pain, disability, diminished motor function, and poor quality of life are the probable outcomes in these untreated patients [1].

The management of these pathologies typically involves conservative management and/or operative procedures. Conservative strategies like physiotherapy, steroid injections, opioids, gabapentinoids, and non-steroidal analgesics provide short-term pain relief. Surgical procedures like discectomy, laminectomy, spine fusion, and decompression surgeries are more effective in moderate-to-severe diseases that do not respond to conservative management. During spine surgeries, various levels of tissue injuries, which include skin, subcutaneous tissue, muscle, periosteum, and bone, can result in varying hemodynamic responses and significant postoperative pain. Poor perioperative pain management can lead to increased opioid consumption, delayed mobilisation, and pulmonary and thromboembolic complications, thereby increasing morbidity and mortality [2].

In the majority of patients, severe pain was reported within four hours of surgery, and it could last up to postoperative day 3 [2]. Opioids are an important class of drugs used in the pharmacological approach. Other systemic analgesics include non-steroidal anti-inflammatory drugs (NSAIDs), ketamine, gabapentin, pregabalin, and dexmedetomidine, which are usually part of a multimodal analgesic regimen [2]. Interventional procedures encompass local infiltration techniques, neuraxial blocks, paravertebral blocks, retrolaminar blocks, and erector spinae plane (ESP) blocks.

In 2016, Forero et al. introduced the ESP block, a novel interfascial plane block that demonstrated remarkable efficacy in chronic neuropathic pain patients. This block provided analgesia by blocking the dorsal rami nerves with minimal complications [3]. Other practitioners also found the ESP block to be a highly effective and viable alternative to paravertebral and epidural blocks for acute postoperative pain in thoracotomy in terms of safety, simplicity, and broad dermatomal coverage [4].

To our knowledge, limited studies have explored the efficacy of ESP block in spine surgeries involving various levels. Therefore, we conducted this study to assess the effectiveness of ESP blocks in posterior spine fusion surgeries at different levels.

The primary objective is to assess postoperative pain by using a visual analogue score (VAS) for 24 hours after spine surgeries, comparing the effect of the ESP block between a general anaesthesia group and a conventional general anaesthesia group. The secondary objectives include comparing the hemodynamic parameters between the two groups, determining the first opioid requirement within 24 hours postoperatively, and evaluating the cumulative opioid consumption during intraoperative and postoperative periods (up to 24 hours).

This article was previously presented by a final-year postgraduate student at the 69th annual national conference of the Indian Society of Anaesthesiologists, dated November 22-27, 2022.

Materials and methods

This single-centre, double-blinded randomised controlled clinical trial was conducted after obtaining institutional ethics committee clearance from Pondicherry Institute of Medical Sciences, Puducherry, India (approval number: RC/2020/94) between 2021 and 2022. The trial was registered in the Clinical Trials Registry-India (CTRI) (CTRI 2021/07/034708) before patient enrolment. We enrolled 56 patients who underwent posterior spine fusion surgery in our institution. Patients with American Society of Anaesthesiologists (ASA) physical status I and II, aged 18-65 years, of both sexes were included. We excluded patients who refused to participate, as well as those with BMI > 35 kg/m, coagulopathy disorders, allergies to the study drug, and undergoing chronic treatment with opioids.

Considering the mean difference in the VAS (control group 3.37 ± 1.35 and study group 2.40 ± 0.89) from the previous study by Yayik et al. [2], with a 95% CI and 80% power, the sample size calculated was 25 in each group. After block randomization and considering 10% attrition of participants, a sample size of 28 in each group was assigned (total n = 56).

All participants were allocated randomly into two groups, conventional (Group C) and ESP (Group E), by using computer-generated block randomization with a block size of seven and eight patients in each block. Group C patients received conventional general anaesthesia with a normal saline (0.9% NaCl) block, and Group E received conventional general anaesthesia with a bilateral ultrasound-guided erector spinae block.

All patients were kept on fasting overnight and premedicated with oral alprazolam 0.25 mg, pantoprazole 40 mg, and metoclopramide 10 mg on the day of surgery. On arrival at the OR, ASA monitoring standards such as ECG, non-invasive blood pressure, pulse oximeter, and baseline parameters were recorded. After securing intravenous access, all patients were preoxygenated for three minutes. General anaesthesia was induced with midazolam 30 mcg/kg IV, fentanyl 2 mcg/kg IV, and propofol 2 mg/kg IV, and muscle relaxation was achieved with vecuronium bromide 0.1 mg/kg IV. After securing the airway with a flexometallic tube of appropriate size, patients were positioned prone to all safety measures. Anaesthesia was maintained with oxygen, nitrous oxide (50:50), and sevoflurane, and muscle relaxation was maintained with intermittent doses of vecuronium bromide (0.02 mg/kg). Under strict aseptic precautions, a high-frequency linear or curvilinear ultrasound probe was placed longitudinally over the spine. The probe slid from the medial to lateral directions, approximately 3 cm from the midline, to identify the erector spinae muscles and the transverse process. Using a 23-gauge Quincke spinal needle, an in-plane approach was used, and the needle tip was placed between the erector spinae muscles and the corresponding transverse process.

For cervical-level surgeries, the needle was introduced at the C7-T1 level and directed in the caudal to the cranial manner. For thoracic and lumbar levels, the needle was introduced one segment above the centre of the proposed instrumentation and directed cranially to the caudal. After confirming the correct needle tip position by hydro dissection, Group C patients received 40 ml of normal saline (0.9% NaCl) (20 ml on each side), and Group E patients received a total 40 ml mixture of 0.25 % bupivacaine + 8 mg dexamethasone (20 ml on each side) below the erector spinae muscles on both sides, respectively. A paracetamol infusion of 15 mg/kg was administered before skin incision and postoperatively every six hours for 24 hours. Heart rate, blood pressure, and mean arterial pressure (MAP) were monitored every 15 minutes until the end of the surgery. Fentanyl 25 mcg IV bolus was administered and documented for any increase in the hemodynamic parameters of >20% of baseline intraoperatively as a rescue analgesic. After surgery, neuromuscular blockade was reversed with neostigmine 50 mcg/kg + glycopyrrolate 10 mcg/kg IV, and the patient was extubated. The VAS score was recorded for every hour during the first 12 hours and the second hour thereafter for 24 hours, and the first opioid analgesic dose of tramadol 50 mg slow IV was given when VAS ≥ 4, and the total postoperative opioid consumption was also monitored for the first 24 hours for both groups. Intraoperative heart rate, blood pressure, and MAP were recorded every 15 minutes after the intervention, and additional intraoperative opioid consumption was documented. All data points were taken from the trend tables on the monitor.

The student unpaired t-test was used to analyse age, weight, height, BMI, and hemodynamic parameters. Sex, ASA, site of surgery, number of levels and different levels of distribution, and intraoperative and postoperative opioid consumption were analysed using a chi-square test. The VAS score was expressed using the Mann-Whitney U test and the repeat analysis of variance test. A P-value of < 0.05 was considered statistically significant.

Results

Fifty-six patients with ASA status I and II who had spine surgeries were randomly allocated into two groups, Group C and Group E, of 28 patients each (Figure 1).

Figure 1. Consort flowchart.

Figure 1

ESP: erector spinae plane

As seen in Table 1, the mean age was found to be 50.29 ± 11.55 in Group C and 48.29 ± 11.84 in Group E. There were 12 female patients and 16 male patients in both groups. The average anthropometry measures in Group C were 64.32 ± 9.71 kg, 160.39 ± 7.06 cm, 25.04 ± 3.88 kg/m2, and in Group E were 65.36 ± 10.81 kg, 164.11 ± 10.40cm, 24.04 ± 3.67 kg/m2. There were nine ASA I patients and 19 ASA II patients in both groups, respectively. All the demographic data were comparable, and there was no significant difference between the two groups.

Table 1. Demographic and clinical characteristics of the participants.

BMI: body mass index; ASA: American Society of Anesthesiologists; Group C: conventional group; Group E: erector spinae plane group

S. No. Variables Group C Group E P-value
1. Age (years) 50.29 ± 11.55 48.29 ± 11.84 0.525 (student unpaired t-test)
2. Gender Female 12 12 0.001 (chi-square test)
Male 16 16
3. Weight 64.32 ± 9.71 kg 65.36 ± 10.81 kg 0.708 (student unpaired t-test)
4. Height 160.39 ± 7.06 cm 164.11 ± 10.40 cm 0.125 (student unpaired t-test)
5. BMI 25.04 ± 3.88 kg/m2 24.04 ± 3.67 kg/m2 0.474 (student unpaired t-test)
6. ASA I 9 9 1.0 (chi-square test)
II 19 19

The mean heart rate was 80.43 ± 12.32 to 90.00 ± 10.02 beats per minute (bpm) in Group C and 58.50 ± 9.19 to 82.93 ± 11.10 bpm in Group E. There was a statistically significant difference between the two groups at the time of incision, 15th to 90th minute, 120th, 180th, 225th, and 240th minute (Table 2, Figure 2).

Table 2. Mean HR among groups.

HR: heart rate; bpm: beats per minute; min: minute; Group C: conventional group; Group E: erector spinae plane group

Time Group N Mean HR (bpm) Standard deviation P-value Mean difference 95% confidence interval of the difference
Lower Upper
Baseline Group C 28 80.46 11.783 0.424 -2.464 -8.599 3.67
Group E 28 82.93 11.102
Incision Group C 28 87.57 16.256 0.007 12.571 3.538 21.605
Group E 28 75 17.438
15 min Group C 28 85.64 14.205 0.004 10.607 3.456 17.758
Group E 28 75.04 12.414
30 min Group C 28 82.57 12.77 0.004 9.536 3.181 15.89
Group E 28 73.04 10.858
45 min Group C 28 83.57 12.261 0.003 9.893 3.588 16.197
Group E 28 73.68 11.245
60 min Group C 28 82.32 15.497 0.021 8.393 1.322 15.464
Group E 28 73.93 10.281
75 min Group C 28 83.79 14.543 0.003 15.75 5.766 25.734
Group E 28 68.04 21.867
90 min Group C 28 82.71 14.102 0.019 8.514 1.455 15.574
Group E 25 74.2 11.464
105 min Group C 25 80.96 13.612 0.152 5.81 -2.233 13.853
Group E 20 75.15 13.011
120 min Group C 24 83.63 10.623 0.013 9.125 2.043 16.207
Group E 18 74.5 11.592
135 min Group C 19 80.84 12.773 0.239 5.019 -3.494 13.531
Group E 17 75.82 12.335
150 min Group C 28 82.74 12.238 0.069 8.09 -0.663 16.843
Group E 28 74.65 13.43
165 min Group C 14 80.43 12.321 0.148 6.929 -2.612 16.469
Group E 14 73.5 12.24
180 min Group C 13 88.31 10.226 0.001 15.665 7.122 24.208
Group E 14 72.64 11.325
195 min Group C 8 84 9.725 0.069 10.6 -0.922 22.122
Group E 10 73.4 13.302
210 min Group C 7 83.43 7.345 0.089 9.129 -1.566 19.823
Group E 10 74.3 13.158
225 min Group C 5 90 10.025 0.02 16.6 3.236 29.964
Group E 10 73.4 12.616
240 min Group C 5 85.6 5.367 0.026 12.378 1.774 22.982
Group E 9 73.22 12.637
255 min Group C 4 87.75 6.238 0.142 12.35 -5.637 30.337
Group E 5 75.4 14.605
270 min Group C 2 89 1.414 0.098 18 -6.033 42.033
Group E 4 71 15.253
285 min Group C 2 82 2.828 0.121 13 -5.724 31.724
Group E 4 69 12.193
300 min Group C 2 87 2.828 0.119 28.5 -31.476 88.476
Group E 2 58.5 9.192

Figure 2. Mean HR among groups.

Figure 2

HR: heart rate; bpm: beats per minute; min: minute; Group C: conventional group; Group E: erector spinae plane group

The mean systolic blood pressure (SBP) ranges from 141.75 mmHg to 116.00 in Group C and 123.61 to 96.75 mmHg in Group E. There was a statistically significant difference between the two groups at the time of incision: 15th to 75th minute, 120th, 210th, 225th, and 285th minute (Table 3).

Table 3. Mean SBP among groups.

SBP: systolic blood pressure; mmHg: millimetre of mercury; SD: standard deviation; min: minute; Group C: conventional group; Group E: erector spinae plane group

Time Group N Mean SBP (mmHg) SD P-value Mean difference 95% confidence interval of the difference
Lower Upper
Baseline Group C 28 118.75 13.517 0.211 -4.857 -12.558 2.844
Group E 28 123.61 15.171
Incision Group C 28 132.61 24.696 0 25.429 14.617 36.24
Group E 28 107.18 13.944
15 min Group C 28 119.93 17.073 0.006 11.714 3.468 19.961
Group E 28 108.21 13.456
30 min Group C 28 120.43 20.973 0.002 15.857 6.171 25.543
Group E 28 104.57 14.49
45 min Group C 28 121.93 18.154 0.019 12.214 2.127 22.302
Group E 28 109.71 19.471
60 min Group C 28 123.79 27.263 0.028 13.214 1.539 24.89
Group E 28 110.57 13.825
75 min Group C 28 122.89 19.458 0.002 16.124 6.472 25.776
Group E 26 106.77 15.794
90 min Group C 28 116.04 18.8 0.157 6.836 -2.729 16.401
Group E 25 109.2 15.869
105 min Group C 25 117.84 16.193 0.084 8.49 -1.204 18.184
Group E 20 109.35 15.849
120 min Group C 23 126.74 23.148 0.001 19.906 8.297 31.515
Group E 18 106.83 13.049
135 min Group C 19 114.32 15.955 0.26 5.551 -4.292 15.394
Group E 17 108.76 13.07
150 min Group C 19 124 29.494 0.076 14.059 -1.601 29.718
Group E 17 109.94 14.541
165 min Group C 14 115.79 12.789 0.286 5.786 -5.13 16.702
Group E 14 110 15.171
180 min Group C 13 126.23 23.41 0.081 14.731 -1.958 31.42
Group E 14 111.5 17.844
195 min Group C 8 125.13 17.117 0.055 17.825 -0.397 36.047
Group E 10 107.3 19.259
210 min Group C 7 124.57 12.726 0.041 17.371 0.842 33.901
Group E 10 107.2 19.234
225 min Group C 5 133.8 21.73 0.034 29.8 3.311 56.289
Group E 9 104 9.552
240 min Group C 5 123.2 9.654 0.022 17.95 3.083 32.817
Group E 8 105.25 14.665
255 min Group C 4 141.75 13.326 0.004 47.5 26.942 68.058
Group E 4 94.25 3.304
270 min Group C 2 128.5 26.163 0.332 31.75 -187.368 250.868
Group E 4 96.75 4.856
285 min Group C 2 115.5 4.95 0.045 16.5 0.714 32.286
Group E 4 99 6.831
300 min Group C 2 116 5.657 0.13 17 -23.487 57.487
Group E 2 99 1.414

The mean diastolic blood pressure (DBP) ranges from 83.75 to 71.43 mmHg in Group C and 77.61 to 59.25 mmHg in Group E. There was a statistically significant difference between the two groups at the time of incision: 15th, 30th, 75th, 120th, 225th, and 255th minutes (Table 4).

Table 4. Mean DBP among groups.

DBP: diastolic blood pressure; min: minute; mmHg: millimetre of mercury; SD: standard deviation; Group C: conventional group; Group E: erector spinae plane group

Time Group N Mean DBP (mmHg) SD P-value Mean difference 95% confidence interval of the difference
Lower Upper
Baseline Group C 28 74.07 9.165 0.147 -3.536 -8.356 1.285
Group E 28 77.61 8.825
Incision Group C 28 78 13.469 0.013 8.214 1.837 14.592
Group E 28 69.79 10.042
15 min Group C 28 78.07 11.382 0.015 7.286 1.47 13.101
Group E 28 70.79 10.293
30 min Group C 28 75.61 12.072 0.01 7.571 1.853 13.29
Group E 28 68.04 9.012
45 min Group C 28 77.07 11.956 0.077 5.929 -0.668 12.525
Group E 28 71.14 12.654
60 min Group C 28 76.89 14.5 0.1 5.321 -1.061 11.703
Group E 28 71.57 8.382
75 min Group C 28 77.04 11.998 0.019 7.151 1.203 13.099
Group E 26 69.88 9.726
90 min Group C 28 71.43 12.677 0.866 -0.531 -6.833 5.77
Group E 25 71.96 10.134
105 min Group C 25 74.24 9.001 0.422 2.34 -3.494 8.174
Group E 20 71.9 10.073
120 min Group C 23 77.83 10.933 0.005 8.833 2.854 14.812
Group E 18 69 8.239
135 min Group C 19 71.68 7.024 0.392 2.214 -2.978 7.406
Group E 17 69.47 8.14
150 min Group C 19 75.95 11.616 0.18 5.183 -2.521 12.886
Group E 17 70.76 11.11
165 min Group C 14 71.64 7.662 0.923 0.357 -7.182 7.896
Group E 14 71.29 11.276
180 min Group C 13 79.54 12.19 0.129 7.396 -2.306 17.097
Group E 14 72.14 12.265
195 min Group C 8 77.13 12.147 0.417 4.925 -7.627 17.477
Group E 10 72.2 12.813
210 min Group C 7 80.43 7.185 0.164 7.529 -3.449 18.506
Group E 10 72.9 13.739
225 min Group C 5 82.4 9.529 0.027 14.178 2.034 26.321
Group E 9 68.22 9.471
240 min Group C 5 74.2 4.207 0.214 4.7 -3.156 12.556
Group E 8 69.5 8.536
255 min Group C 4 83.75 8.958 0.005 24.5 10.765 38.235
Group E 4 59.25 6.185
270 min Group C 2 82.5 17.678 0.351 20.25 -134.141 174.641
Group E 4 62.25 2.062
285 min Group C 2 72 2.828 0.06 8.75 -0.784 18.284
Group E 4 63.25 3.202
300 min Group C 2 72 2.828 0.069 11 -2.837 24.837
Group E 2 61 1.414

The average MAP in Group C was 86.50 to 104.00 mmHg, and in Group E it was 72.25 to 93.64 mmHg. There was a significant difference in MAP between two groups at the time of incision: 15th to 45th minute, 75th, 120th, 225th, 255th, and 300th minute (Figure 3).

Figure 3. MAP among groups.

Figure 3

MAP: mean arterial pressure; mmHg: millimetres of mercury; min: minute; Group C: conventional group; Group E: erector spinae plane group

The mean additional intraoperative fentanyl consumption was 1.22 mg in Group C and 125 mcg in Group E (Table 5). The difference between the two groups was statistically significant at the time of incision (0.036), 60th minute (0.023), and 120th minute (0.023).

Table 5. Intraoperative cumulative additional opioid dose among groups.

In Group C, we repeated fentanyl 42 times, and the cumulative dose was 1.05 mg. In Group E, we repeated fentanyl only five times, and the cumulative dose was 125 mcg

Group C: conventional group; Group E: erector spinae plane group; mg: milligrammes; mcg: micrograms

Intraoperative cumulative fentanyl dose Group C Group E
Total number of repeated doses 42 5
Cumulative dose 1.05 mg 125 mcg

The average VAS score was 5.96 to 2.68 in Group C and 3.32 to 2.11 in Group E. There was a statistically significant difference in VAS between the two groups from the first to the seventh hour, 12th, 14th, 16th, 20th, and 24th hour postoperatively (Table 6, Figure 4).

Table 6. Mean VAS among groups.

VAS: visual analogue score; hr: hour; VAS ranges: 0-10; Group C: conventional group; Group E: erector spinae plane group; IQR: interquartile range

Time Group N Mean Standard deviation Median IQR P-value Mean difference 95% confidence interval of the difference
Lower Upper
1st hr Group C 28 5.96 2.236 6.500 3.0 <0.001 2.643 1.534 3.752
Group E 28 3.32 1.887 3.000 1.0
2nd hr Group C 28 2.93 0.979 3.000 1.0 0.001 0.571 0.086 1.057
Group E 28 2.36 0.826 2.000 1.0
3rd hr Group C 28 2.93 0.979 3.000 1.0 <0.001 0.714 0.295 1.134
Group E 28 2.21 0.499 2.000 1.0
 4th hr Group C 28 2.68 1.056 2.000 1.0 0.010 0.571 0.125 1.018
Group E 28 2.11 0.497 2.000 0.0
5th hr Group C 28 3.89 2.347 3.000 4.0 0.007 1.357 0.273 2.441
Group E 28 2.54 1.621 2.000 1.0
6th hr Group C 28 3.61 1.571 3.000 2.0 <0.001 1.464 0.827 2.101
Group E 28 2.14 0.525 2.000 0.0
7th hr Group C 28 3.21 1.343 3.000 1.0 0.006 0.786 0.235 1.336
Group E 28 2.43 0.504 2.000 1.0
8th hr Group C 28 2.93 1.016 3.000 1.0 0.471 0.036 -0.568 0.640
Group E 28 2.89 1.227 3.000 1.0
9th hr Group C 28 3.32 1.744 3.000 1.0 0.251 0.464 -0.329 1.258
Group E 28 2.86 1.145 2.500 1.0
10th hr Group C 28 3.00 1.515 3.000 1.0 0.222 0.429 -0.239 1.096
Group E 28 2.57 .879 2.000 1.0
11th hr Group C 28 2.79 1.134 2.500 1.0 0.116 0.357 -0.187 0.901
Group E 28 2.43 0.879 2.000 1.0
12th hr Group C 28 3.93 1.844 3.000 4.0 0.024 1.036 0.181 1.890
Group E 28 2.89 1.286 2.000 1.0
14th hr Group C 28 3.46 1.710 3.000 3.0 0.005 1.107 0.415 1.799
Group E 28 2.36 0.559 2.000 1.0
16th hr Group C 28 2.71 0.937 3.000 1.0 0.017 0.357 -0.159 0.874
Group E 28 2.36 0.989 2.000 0.0
18th hr Group C 28 2.93 1.152 3.000 1.0 0.073 .429 -0.122 0.979
Group E 28 2.50 0.882 2.000 1.0
20th hr Group C 28 3.79 1.729 3.000 4.0 0.013 1.071 0.282 1.861
Group E 28 2.71 1.150 2.000 1.0
22nd hr Group C 28 2.89 0.956 3.000 1.0 0.105 0.321 -0.171 0.814
Group E 28 2.57 0.879 2.000 1.0
24th hr Group C 28 3.11 1.315 3.000 2.0 0.001 0.893 0.353 1.433
Group E 28 2.21 0.499 2.000 0.0

Figure 4. Mean VAS among groups.

Figure 4

VAS: visual analogue scale; hr: hour; Group C: conventional group; Group E: erector spinae plane group

The cumulative postoperative opioid requirement was 5700 mg in Group C and 2000 mg in Group E (Table 7). There was a significant difference in postoperative opioid consumption between the two groups at the first, fifth, sixth, 14th, 20th, and 24th hours.

Table 7. Mean postoperative opioid requirement among groups.

In Group C, we repeated tramadol 114 times, and the cumulative dose was 5700 mg. In Group E, we repeated tramadol only 40 times, and the cumulative dose was 2000 mg

Group C: conventional group; Group E: erector spinae plane group; mg: milligrammes; mcg: micrograms

Postoperative cumulative tramadol dose Group C Group E
Total number of repeated doses 114 40
cumulative dose 5700 mg 2000 mg

The distribution of postoperative first opioid requirement was found to be higher in Group C than in Group E at the first, fifth, sixth, 14th, 20th, and 24th hour (Table 8). There was no significant difference in the additional opioid or NSAID consumption between the two groups at any given time.

Table 8. Distribution of the postoperative first opioid requirement.

Group C: conventional group; Group E: erector spinae plane group; hr: hour

Time Group N Postoperative opioid required No postoperative opioid required P-value
1st hr Group C 28 22 6 <0.001
Group E 28 4 24
2nd hr Group C 28 2 26 0.491
Group E 28 0 28
3rd hr Group C 28 2 26 0.491
Group E 28 0 28
4th hr Group C 28 2 26 0.491
Group E 28 0 28
5th hr Group C 28 9 19 0.019
Group E 28 2 26
6th hr Group C 28 8 20 0.004
Group E 28 0 28
7th hr Group C 28 4 24 0.111
Group E 28 0 28
8th hr Group C 28 3 25 1
Group E 28 4 24
9th hr Group C 28 5 23 1
Group E 28 5 23
10th hr Group C 28 3 25 1
Group E 28 3 25
11th hr Group C 28 3 25 1
Group E 28 2 26
12th hr Group C 28 11 17 0.146
Group E 28 6 22
14th hr Group C 28 8 20 0.025
Group E 28 1 27
16th hr Group C 28 2 26 1
Group E 28 1 27
18th hr Group C 28 5 23 0.705
Group E 28 3 25
20th hr Group C 28 13 15 0.009
Group E 28 4 24
22th hr Group C 28 4 24 1
Group E 28 4 24
24th hr Group C 28 8 20 0.025
Group E 28 1 27

Discussion

Spine surgeries result in intraoperative hemodynamic disturbances due to sympathetic stimulation and severe postoperative pain due to large incisions and tissue handling, which cannot be tolerated by all patients. Adequate perioperative analgesia in spine surgery plays a vital role in attenuating surgical stress response, better recovery, and early ambulation in the postoperative period.

The routine practice is to use a pharmacological approach rather than interventional methods. Drugs such as opioids, NSAIDs, and ketamine, as well as non-opioids like gabapentin, pregabalin, dexmedetomidine, and others, can be used as part of multimodal analgesia. Increasing the dose of these analgesics can reduce the pain, but they are associated with other side effects like delayed recovery, postoperative desaturation, postoperative nausea, vomiting, urinary retention, etc. On the other hand, we have interventional methods like local infiltration, neuraxial techniques, paravertebral blocks, and ESP blocks that will effectively block the afferent pain signals, as they not only reduce the opioid and inhalational anaesthetic requirements but also postoperative complications.

In literature, the majority of ESP blocks were performed solely on the lumbar level [5-7]. We assessed the effectiveness of ESP block at various levels of posterior spine surgeries (cervical, thoracic, and lumbar) by parameters such as intraoperative opioid consumption, hemodynamics, time duration for the first rescue analgesia postoperatively, and the total amount of opioid requirement for the first 24 hours postoperatively.

The needle orientation is a key factor in the ESP block because it determines the drug spread. Kanna et al. assessed the drug spread in caudal to cranial needle orientation at the level of the T1 vertebra for posterior cervical spine surgeries, which resulted in excellent cephalad spread of the drug and superior perioperative pain relief [8]. Similarly, in our study for the cervical level, the needle was directed from the caudal to the cephalad from one segment below the skin incision. We found that there was a good local anaesthetic (LA) spread of cephalad, which resulted in good pain relief.

Finnerty et al. performed ESP block at the T5 level for minimally invasive thoracic surgeries, and they directed the needle in a cranial to caudal manner. They found that the ESP block was superior to the serratus anterior plane block and no longer needed for rescue analgesia in the ESP group [9]. Likewise, in our study, at the thoracic level, the needle was introduced in the cranial to caudal direction from one vertebra above the level of the surgery, resulting in a diffuse spread of LA and a good analgesic effect.

Yayik et al. performed ESP block at the L3 level for lumbar spine surgeries, in which they introduced the needle in a cranial to caudal direction, resulting in adequate spread through the entire lumbar level [2]. In our study, the needle was oriented in the cranial to the caudal direction at the L3-L4 level, resulting in excellent spread of the drug and a greater analgesic effect.

Concerning age, gender, height, weight, BMI, and ASA grading, there were no statistically significant differences, and the two groups were comparable.

Singh et al. assessed the postoperative pain score with a numerical rating scale in patients who received bilateral ESP blocks for lumbar spine surgeries. They found that the pain score was significantly higher in the control group immediately after surgery and at six hours than in the ESP block group, and the satisfaction score was higher in the ESP block group (P < 0.0001) [10].

Yayik et al. found that the VAS scores were significantly lower in the ESP group than in the control group in patients who underwent lumbar spinal decompression surgery [2].

Similarly, in our study, the visual analogue score was assessed between two groups at various intervals. The Group E patients had lower VAS scores compared to Group C for the first seven hours and at 12, 14, 16, 20, and 24 hours postoperatively, and it was statistically significant (P < 0.001). This signifies that there was no requirement for analgesics postoperatively until seven hours in the ESP block group when compared to the conventional group. The site-specific blockade of the dorsal rami of the spinal nerves helps to achieve greater analgesia for patients in the postoperative period.

Ghamry et al. showed that there was a significant increase in HR and MAP in the general anaesthesia group rather than general anaesthesia with ESP block at various time intervals in patients who underwent posterior lumbar interbody fusion [11].

Based on an observational study by Zhang et al. on volunteers, the ESP block produced cutaneous sensory loss from T6-T9 and was probably due to the involvement of the dorsal rami of spinal nerves [12].

Likewise, in our study, heart rate was significantly low, especially at the time of incision: 15th to 90th, 120th, 180th, 225th, and 240th minutes in the ESP block (P = 0.045). The SBP was significantly lower at the time of incision: 15th to 75th, 120th, 225th, and 285th minutes. Similarly, DBP was significantly low in Group E at the time of incision: 15th, 30th, 75th, 120th, 225th, and 255th minutes. MAP was found to be higher in Group C patients than Group E patients, and the difference between the two groups was statistically significant at the time of incision: 15th to 45th, 75th, 120th, 225th, 255th, and 300th minutes. The controlled hemodynamics were probably due to superior analgesia provided by effectively blocking the dorsal rami of spinal nerves.

Goel et al., in their study, found that ESP group patients had low fentanyl consumption compared to the conventional general anaesthesia group [13].

Correspondingly, in our study, Group C patients had higher opioid requirements than Group E patients at the time of incision: 60th and 120th minutes. Higher-quality analgesia provided by the ESP block reduced opioid consumption intraoperatively. With the ESP block, the amount of opioid consumption and the associated side effects were found to be reduced.

Similarly, Wahdan et al. explained in their study that morphine consumption was higher in the control group than in the ESP block group in the postoperative period [14].

The rescue analgesia in our study was tramadol 50 mg intravenously. Both groups received 1 gm of acetaminophen every eighth hour until 24 hours as part of multimodal analgesia. We found that tramadol consumption was significantly higher in Group C than in Group E at different periods. The longer duration of postoperative analgesia could be due to the effect of the dexamethasone additive in the block [15].

The main limitation of our study was that we could not evaluate the extent of sensory blockade as we performed the procedure after GA. Patient-controlled analgesia was not used, which would have helped us to refine the time intervals and quantify the exact amount of opioid requirements. In our study, we did not standardise the number of patients at a particular spine level. Recovery questionnaires were not assessed to determine the long-term quality of life after the ESP block.

Conclusions

The ESP block is a site-specific dorsal ramus block with a better perioperative hemodynamic profile. When used as a part of multimodal analgesia, it provides excellent intraoperative and postoperative analgesia with fewer postoperative opioid requirements in multilevel spine fusion surgeries.

The authors have declared that no competing interests exist.

Author Contributions

Concept and design:  Arish BT, Suresh Kumar, Eashwar Neelakandan, Ranjan RV, Sivakumar Segaran, Prince Solomon

Acquisition, analysis, or interpretation of data:  Arish BT, Suresh Kumar, Eashwar Neelakandan, Ranjan RV, Sivakumar Segaran, Prince Solomon

Drafting of the manuscript:  Arish BT, Suresh Kumar, Eashwar Neelakandan, Ranjan RV, Sivakumar Segaran

Critical review of the manuscript for important intellectual content:  Arish BT, Suresh Kumar, Eashwar Neelakandan, Ranjan RV, Sivakumar Segaran, Prince Solomon

Supervision:  Arish BT, Eashwar Neelakandan, Ranjan RV, Sivakumar Segaran

Human Ethics

Consent was obtained or waived by all participants in this study. Pondicherry Institute of Medical Sciences Institutional Ethics Committee issued approval RC/2020/94

Animal Ethics

Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue.

References

  • 1.Erector spinae plane block combined with general anaesthesia versus conventional general anaesthesia in lumbar spine surgery. Siam EM, Abo Aliaa DM, Elmedany S, Abdelaa ME. Egypt J Anaesth. 2020;36:201–226. [Google Scholar]
  • 2.Postoperative analgesic efficacy of the ultrasound-guided erector spinae plane block in patients undergoing lumbar spinal decompression surgery: a randomized controlled study. Yayik AM, Cesur S, Ozturk F, Ahiskalioglu A, Ay AN, Celik EC, Karaavci NC. World Neurosurg. 2019;126:779–785. doi: 10.1016/j.wneu.2019.02.149. [DOI] [PubMed] [Google Scholar]
  • 3.The erector spinae plane block: a novel analgesic technique in thoracic neuropathic pain. Forero M, Adhikary SD, Lopez H, Tsui C, Chin KJ. Reg Anesth Pain Med. 2016;41:621–627. doi: 10.1097/AAP.0000000000000451. [DOI] [PubMed] [Google Scholar]
  • 4.Erector spinae plane (ESP) block in the management of post thoracotomy pain syndrome: a case series. Forero M, Rajarathinam M, Adhikary S, Chin KJ. Scand J Pain. 2017;17:325–329. doi: 10.1016/j.sjpain.2017.08.013. [DOI] [PubMed] [Google Scholar]
  • 5.The efficacy of intraoperative freehand Erector spinae plane block in lumbar spondylolisthesis: a randomized controlled study. Yeşiltaş S, Abdallah A, Uysal Ö, Yilmaz S, Çinar İ, Karaaslan K. Spine (Phila Pa 1976) 2021;46:902–910. doi: 10.1097/BRS.0000000000003966. [DOI] [PubMed] [Google Scholar]
  • 6.Efficacy of the erector spinae plane block for lumbar spinal surgery: a retrospective study. Ueshima H, Inagaki M, Toyone T, Otake H. Asian Spine J. 2019;13:254–257. doi: 10.31616/asj.2018.0114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.The analgesic efficacy of erector spinae plane blocks in patients undergoing posterior lumbar spinal surgery for lumbar fracture. Yu Y, Wang M, Ying H, Ding J, Wang H, Wang Y. World Neurosurg. 2021;147:1–7. doi: 10.1016/j.wneu.2020.10.175. [DOI] [PubMed] [Google Scholar]
  • 8.Perioperative analgesic efficacy and safety of erector spinae plane block in posterior cervical spine surgery-a double blinded, randomized controlled study. Kanna RM, Ramachandran K, Subramanian JB, Shetty AP, Rajasekaran S. Spine J. 2023;23:6–13. doi: 10.1016/j.spinee.2022.04.010. [DOI] [PubMed] [Google Scholar]
  • 9.Comparing erector spinae plane block with serratus anterior plane block for minimally invasive thoracic surgery: a randomised clinical trial. Finnerty DT, McMahon A, McNamara JR, Hartigan SD, Griffin M, Buggy DJ. Br J Anaesth. 2020;125:802–810. doi: 10.1016/j.bja.2020.06.020. [DOI] [PubMed] [Google Scholar]
  • 10.Bilateral ultrasound-guided Erector spinae plane block for postoperative analgesia in lumbar spine surgery: a randomized control trial. Singh S, Choudhary NK, Lalin D, Verma VK. J Neurosurg Anesthesiol. 2020;32:330–334. doi: 10.1097/ANA.0000000000000603. [DOI] [PubMed] [Google Scholar]
  • 11.Ultrasound-guided erector spinae plane block for acute pain management in patients undergoing posterior lumbar interbody fusion under general anaesthesia. Ghamry MR, Elgebaly AS, Anwar AG, Shaddad MN. South Afr J Anaesth Analg. 2019;25:26–31. [Google Scholar]
  • 12.The erector spinae plane block causes only cutaneous sensory loss on ipsilateral posterior thorax: a prospective observational volunteer study. Zhang J, He Y, Wang S, et al. BMC Anesthesiol. 2020;20:88. doi: 10.1186/s12871-020-01002-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Clinical efficacy of ultrasound guided bilateral erector spinae block for single-level lumbar fusion surgery: a prospective, randomized, case-control study. Goel VK, Chandramohan M, Murugan C, Shetty AP, Subramanian B, Kanna RM, Rajasekaran S. Spine J. 2021;21:1873–1880. doi: 10.1016/j.spinee.2021.06.015. [DOI] [PubMed] [Google Scholar]
  • 14.Effect of bilateral ultrasound-guided erector spinae blocks on postoperative pain and opioid use after lumbar spine surgery: a prospective randomized controlled trial. Wahdan AS, Radwan TA, Mohammed MM, Mohamed AA, Salama AK. Egypt J Anaesth. 2021;37:100–106. [Google Scholar]
  • 15.Ultrasound-guided thoracolumbar interfascial plane block with and without dexamethasone: a comparative study in patients undergoing lumbar spine surgeries. Tarigonda S, Papireddy SM, Senthamarai S, Voleti V, Srinivasa M. https://journals.lww.com/mjdy/fulltext/9000/ultrasound_guided_thoracolumbar_interfascial_plane.99762.aspx Med J Dr D Y Patil Vidyapeeth. 2023 [Google Scholar]

Articles from Cureus are provided here courtesy of Cureus Inc.

RESOURCES